BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36263778)

  • 21. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
    Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrophic gastritis in Helicobacter pylori-infected children.
    Hsieh H; Yang HB; Sheu BS; Yang YJ
    Helicobacter; 2022 Jun; 27(3):e12885. PubMed ID: 35306717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and predictors of gastric cancer after
    Shichijo S; Hirata Y
    World J Gastroenterol; 2018 May; 24(20):2163-2172. PubMed ID: 29853734
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.
    Suzuki M; Suzuki H; Masaoka T; Tanaka S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():158-64. PubMed ID: 15298622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
    Kodama M; Okimoto T; Mizukami K; Hirashita Y; Wada Y; Fukuda M; Matsunari O; Okamoto K; Ogawa R; Fukuda K; Kudo Y; Kawahara Y; Murakami K
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2210-2216. PubMed ID: 33656793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
    Na YS; Kim SG; Cho SJ
    Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coding and non-coding co-expression network analysis identifies key modules and driver genes associated with precursor lesions of gastric cancer.
    Lario S; Ramírez-Lázaro MJ; Brunet-Vega A; Vila-Casadesús M; Aransay AM; Lozano JJ; Calvet X
    Genomics; 2022 May; 114(3):110370. PubMed ID: 35430283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
    Watari J; Tanaka A; Tanabe H; Sato R; Moriichi K; Zaky A; Okamoto K; Maemoto A; Fujiya M; Ashida T; Das KM; Kohgo Y
    J Clin Pathol; 2007 Aug; 60(8):921-6. PubMed ID: 16997920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
    Shiotani A; Uedo N; Iishi H; Tatsuta M; Ishiguro S; Nakae Y; Kamada T; Haruma K; Merchant JL
    Int J Cancer; 2007 Sep; 121(6):1182-9. PubMed ID: 17520681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication.
    Hwang YJ; Choi Y; Kim N; Lee HS; Yoon H; Shin CM; Park YS; Lee DH
    Dig Dis Sci; 2022 Jul; 67(7):3055-3066. PubMed ID: 34365533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of mutant type-p53 products in H pylori-associated chronic gastritis.
    Kodama M; Murakami K; Okimoto T; Sato R; Watanabe K; Fujioka T
    World J Gastroenterol; 2007 Mar; 13(10):1541-6. PubMed ID: 17461446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
    Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum.
    Hsu PI; Lai KH; Tseng HH; Lin CK; Lo GH; Cheng JS; Chan HH; Hsu JH; Jou HS; Ger LP; Chen W; Hsu PN
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):279-87. PubMed ID: 10820906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of Helicobacter pylori eradication on chronic gastritis].
    Kodama M; Murakami K; Okimoto T; Fujioka T
    Nihon Rinsho; 2013 Aug; 71(8):1442-8. PubMed ID: 23967677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
    Chen HN; Wang Z; Li X; Zhou ZG
    Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
    Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
    World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.